Gilead Share Price

Gilead Share Price

NASDAQ: GILD | Mega Cap | Healthcare
$169.27
-$0.98 (-0.58%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

Gilead Stock Performance

Open
$167.91
Prev. Close
$170.25
Circuit Range
N/A
Day Range
$167.84 - $170.48
Year Range
$116.93 - $176.56
Volume
2,18,924
Average Traded
$168.87

Gilead Share Price Today

As of 19 November 2026, Gilead Sciences, Inc.'s share price is $169.27. The stock opened at $167.91, compared to its previous close of $170.25. During today's trading session, Gilead Sciences, Inc.'s share price traded between $167.84 and $170.48, with an average price of $169.16. Over the past 52 weeks, the stock has recorded a high of $176.56 and a low of $116.93. In terms of performance, Gilead Sciences, Inc.'s share price has risen by 25.89% over the last six months and is up 34.50% on a year-on-year basis.

Gilead Share Price Chart

Line chart of the Gilead price trend over the selected period. The price fell overall, ranging from 167.91 to 170.48, ending at 169.27.
$167.84$170.48
L
Show Current Price
H

Gilead Stock Fundamentals & Key Indicators

Market Cap
$210.57B
PE Ratio (TTM)
N/A
Dividend Yield
1.94%
EPS (TTM)
$-3.11
Revenue (TTM)
$29.44B
Return On Equity (TTM)
-29.62%
Profit Margin
28.91%
Debt to Equity
2.01
Quarterly Earnings Growth YoY
11.47%

Gilead Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$7.93$6.96$7.80$8.30
Net Profit$2.18$2.02-$10.50$2.43
Net Profit Margin27.49%29.02%-134.62%29.28%
Income ChangeN/A-7.34%-619.80%123.14%

Gilead Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$27.28$27.12$28.75$29.44
Net Profit$4.59$5.67$0.48$8.51
Net Profit Margin16.83%20.91%1.67%28.91%
Income ChangeN/A23.53%-91.53%1672.92%

Gilead Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets40.6839.8246.0448.73
Current Assets18.3419.1716.0914.44
Total Assets59.0259.062.1363.17
Non Current Liabilities24.5927.7528.130.73
Current Liabilities11.8112.011.2811.24
Total Liabilities36.4139.7539.3841.96
Shareholders' Equity22.6219.2522.7521.21

Gilead Cash Flow

Annually
Particulars2025202420232022
Operating (USD Billion)10.010.88.09.1
Investing (USD Million)-4,794.0-3,449.0-2,265.0-2,466.0
Financing (USD Million)-7,745.0-3,433.0-5,125.0-6,469.0

Corporate Actions

Dividend
Ex-date: 15 Dec 2026

Dividend
Ex-date: 15 Sep 2026

Dividend
Ex-date: 15 Jun 2026

Dividend
Ex-date: 13 Mar 2026

Dividend
Ex-date: 15 Dec 2025

Dividend
Ex-date: 15 Sep 2025

Dividend
Ex-date: 13 Jun 2025

Dividend
Ex-date: 14 Mar 2025

Dividend
Ex-date: 13 Dec 2024

Dividend
Ex-date: 13 Sep 2024

Dividend
Ex-date: 14 Jun 2024

Dividend
Ex-date: 14 Mar 2024

About Gilead

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$169.51
$169.28
-0.83%
Oct 2026
$149.44
$170.70
+14.41%
Sep 2026
$147.87
$149.19
+0.24%
Aug 2026
$131.20
$148.84
+14.33%
Jul 2026
$127.19
$130.19
+3.13%
Jun 2026
$133.43
$126.24
-6.11%
May 2026
$130.16
$134.46
+2.76%
Apr 2026
$139.01
$130.84
-6.10%
Mar 2026
$147.87
$139.35
-6.46%
Feb 2026
$141.26
$148.97
+4.92%
Jan 2026
$122.41
$141.98
+15.65%
Dec 2025
$125.84
$122.77
-2.46%

Gilead Share Price FAQs